|
Market Cap (17-May) $40,671,720 (1,053rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 400,697 |
Shortsold (10-Dec) 1,128,575 (0.62%) (255th) |
|
52w High $0.345 |
52w Low $0.140 |
P/E - |
EPS -0.05 |
CYP released this announcement to the ASX on 27 January 2022, 9:25. The announcement is marked as price sensitive, and is 2 page(s) in length and 248.67kb in size.
You can view all announcements from CYP and see how they appear on a price chart on the announcements page.
At the date of this announcement, CYP was 0.019% short sold according to ASIC data. It was ranked the 586th most shorted stock on the ASX. It is now ranked as the 255th most shorted stock on the ASX with 0.624% of total shares short sold as of the latest reported data (10 December 2024).
| Other Recent Announcements from CYP | |
|---|---|
| Notification regarding unquoted securities - CYP | 30 June 2023, 13:10 |
| Proposed issue of securities - CYP | 30 June 2023, 9:44 |
| Cynata announces CEO succession and Board changes | 30 June 2023, 9:13 |
| Cynata Receives Decision to Grant a Patent in Japan | 27 January 2022, 9:25 |
| Cynata Receives $832,677 R&D Tax Incentive Refund | 19 January 2022, 9:24 |
| FUJIFILM Cellular Dynamics Executes Manufacturing Agreement | 29 December 2021, 9:32 |
| Cynata Commences DFU Clinical Trial | 22 December 2021, 8:43 |
You must be logged in to post a reply.
Cynata Therapeutics 